KELLY HAMM: Open Payments
NPI 1629634746 · NEW CASTLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,318 in 51 payments from 11 companies in 2025. Trend: 2023 $1,735 · 2024 $1,781 · 2025 $1,318
Food & beverage: $1,318
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 21 | $785 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $91 |
| Axsome Therapeutics, Inc. | 5 | $90 |
| Corium, LLC | 5 | $80 |
| ABBVIE INC. | 5 | $75 |
| Lundbeck LLC | 4 | $63 |
| Otsuka America Pharmaceutical, Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $28 |
| Biogen, Inc. | 1 | $20 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
Products named: ARISTADA, LYBALVI, REXULTI, CAPLYTA, Azstarys, VRAYLAR, Auvelity, Sunosi.
Industry payments across IN — which companies pay providers there.
